儿童重症监护病房234例死亡病例中疑似遗传病的遗传病因分析
该回顾性队列研究纳入2017年1月至2021年12月复旦大学附属儿科医院PICU怀疑遗传病入院后7 d内死亡的234例患儿,根据基因检测结果分为致病性基因变异阳性组(62例,26.5%)和阴性组(172例)。阳性组死亡年龄更低,家族史和慢性复杂疾病比例更高,入院时重症感染、精神反应差或昏迷、中重度贫血、血小板减少、迁延性腹泻、肌力或肌张力异常比例均更高。主要致病基因涉及免疫、代谢和神经肌肉系统。
要点
- PICU死亡病例中致病性基因变异阳性率为26.5%,以免疫、代谢和神经肌肉基因变异为主。
- 基因变异阳性患儿死亡年龄更低,家族史和慢性复杂疾病比例更高。
- 存在重症感染、意识障碍、贫血、血小板减少、迁延性腹泻或肌力异常应尽早行基因检测。
核心结论
- PICU死亡病例的主要遗传病因为免疫相关、代谢和神经肌肉遗传病基因变异。
- 对存在家族史、慢性复杂疾病及特定早期临床特征的危重患儿应尽早行基因检测。
研究设计与样本
- 回顾性队列研究,纳入2017年1月至2021年12月复旦大学附属儿科医院PICU怀疑遗传病入院后7 d内死亡的234例患儿。
- 根据基因检测结果分为致病性基因变异阳性组(62例)和阴性组(172例),比较组间临床特征。
主要发现
- 234例中男139例(59.4%)、女95例(40.6%),死亡年龄1.0(0.4,3.7)岁,住院时长16(6,33)d。
- 致病性基因变异阳性62例(26.5%),变异基因包括免疫基因23例(37.1%)、代谢基因11例(17.7%)、神经肌肉基因11例(17.7%)、心血管基因4例(6.5%)、其他系统基因13例(21.0%)。
- 阳性组死亡年龄低于阴性组[0.6(0.3,1.4)比1.3(0.5,4.3)岁,Z=3.85,P<0.001]。
- 阳性组家族史和慢性复杂疾病比例均高于阴性组[6.5%(4/62)比0.6%(1/172)、93.5%(58/62)比76.2%(131/172),χ²=8.87,P=0.018、0.003]。
- 出现2次以上的致病基因包括IL2RG(5例)、SMN1(4例)、SH2D1A(3例,包括2例单基因变异和1例拷贝数变异)。
关键数值与推荐
- 阳性组入院时重症感染比例74.2%(46/62)高于阴性组45.9%(79/172),χ²=14.63,P<0.05。
- 阳性组精神反应差或昏迷比例50.0%(31/62)高于阴性组35.5%(61/172),χ²=4.04,P<0.05。
- 阳性组中重度贫血比例32.3%(20/62)高于阴性组18.0%(31/172),χ²=5.41,P<0.05。
- 阳性组血小板减少比例21.0%(13/62)高于阴性组10.5%(18/172),χ²=4.37,P<0.05。
- 阳性组迁延性腹泻比例25.8%(16/62)高于阴性组4.1%(7/172),χ²=24.30,P<0.05;肌力或肌张力异常比例16.1%(10/62)高于阴性组5.2%(9/172),χ²=7.25,P<0.05。
临床怎么用
- 对PICU危重患儿,若存在家族史、慢性复杂疾病,或入院时出现重症感染、精神反应差或昏迷、中重度贫血、血小板减少、迁延性腹泻、肌力或肌张力异常,应重点关注并尽早行基因检测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To explore the genetic etiology of pediatric intensive care unit (PICU) mortality cases and summarize their clinical characteristics. Methods: This was a retrospective cohort study. The study population consisted of 234 children who died within 7 d after admitted to the PICU of Children's Hospital of Fudan University from January 2017 to December 2021. The clinical diagnoses, laboratory test results, and genetic testing results were collected. These patients were divided into the pathogenic gene variation positive (PGVP) group and the pathogenic gene variation negative (PGVN) group according to the results of genetic testing. The Mann-Whitney U test and Pearson's chi-square test or Fisher's exact probability method were used to compare the clinical characteristics between the groups. Results: A total of 234 cases were enrolled, including 139 (59.4%) males and 95 (40.6%) females. The age at death was 1.0 (0.4, 3.7) years old and the length of PICU stay was 16 (6, 33) days. There were 62 cases (26.5%) PGVP, and the mutated pathogenic genes included immune genes (23 cases (37.1%)), metabolic genes (11 cases (17.7%)), neuromuscular genes (11 cases (17.7%)), cardiovascular genes (4 cases (6.5%)), and genes of other systems (13 cases (21.0%)). The age at death in PGVP cases was significantly lower than in PGVN cases (0.6 (0.3, 1.4) vs. 1.3(0.5, 4.3) years old, Z=3.85, P<0.001). Compared with the PGVN group, the PGVP group had a higher incidence of family history and chronic complex conditions (CCC) than the PGVN group (6.5% (4/62) vs. 0.6% (1/172) and 93.5% (58/62) vs. 76.2% (131/172), χ2=8.87, P=0.018 and 0.003, respectively). Children in the PGVP group were admitted with higher incidence of severe infection, decreased consciousness or coma, moderate-to-severe anemia, thrombocytopenia, protracted diarrhea, and abnormalities in muscle strength or tone than those in the PGVN group (74.2%(46/62) vs. 45.9%(79/172), 50.0%(31/62) vs. 35.5%(61/172), 32.3%(20/62) vs. 18.0%(31/172), 21.0%(13/62) vs. 10.5%(18/172), 25.8%(16/62) vs. 4.1%(7/172), 16.1%(10/62) vs. 5.2%(9/172), χ2=14.63, 4.04, 5.41, 4.37, 24.30, 7.25, all P<0.05). Pathogenic genes that occurred more than twice included IL2RG (5 cases), SMN1 (4 cases), and SH2D1A (3 cases, including 2 single gene varients and 1 copy number varient). Conclusions: Among the deceased cases in the PICU, the main genetic causes are immune-related, metabolic, and neuromuscular genetic disorders. Critically ill children with a family history, CCC, and early features such as severe infections, decreased consciousness or coma, moderate to severe anemia, thrombocytopenia, protracted diarrhea, or abnormalities in muscle strength or tone should be closely monitored and undergo early genetic testing. 目的: 探索儿童重症监护病房(PICU)死亡病例的遗传病因并总结其临床特征。 方法: 回顾性队列研究。选择2017年1月至2021年12月复旦大学附属儿科医院PICU怀疑遗传病入院后7 d内死亡的234例患儿为研究对象,收集临床诊断、实验室检查等临床信息和基因检测结果,根据基因检测结果分为致病性基因变异阳性(PGVP)组和致病性基因变异阴性(PGVN)组,采用Mann-Whitney U检验和Pearson χ²检验或Fisher确切概率法比较组间的临床特征差异。 结果: 234例死亡病例中男139例(59.4%)、女95例(40.6%),死亡年龄为1.0(0.4,3.7)岁,住院时长为16(6,33)d。其中PGVP组62例(26.5%),变异的致病性基因包括免疫基因[23例(37.1%)]、代谢基因[11例(17.7%)]、神经肌肉基因[11例(17.7%)]、心血管基因[4例(6.5%)]和其他系统基因[13例(21.0%)]。PGVP组的死亡年龄低于PGVN组[0.6(0.3,1.4)比1.3(0.5,4.3)岁,Z=3.85,P<0.001];存在家族史和慢性复杂疾病(CCC)的情况均多于PGVN组[6.5%(4/62)比0.6%(1/172)、93.5%(58/62)比76.2%(131/172),χ2=8.87,P=0.018、0.003]。PGVP组患儿入院存在重症感染、精神反应差或昏迷、中重度贫血、血小板减少、迁延性腹泻、肌力或肌张力异常的比例均高于PGVN组[74.2%(46/62)比45.9%(79/172)、50.0%(31/62)比35.5%(61/172)、32.3%(20/62)比18.0%(31/172)、21.0%(13/62)比10.5%(18/172)、25.8%(16/62)比4.1%(7/172)、16.1%(10/62)比5.2%(9/172),χ2=14.63、4.04、5.41、4.37、24.30、7.25,均P<0.05]。出现2次以上的致病基因包括IL2RG(5例)、SMN1(4例)、SH2D1A(3例,包括2例单基因变异和1例拷贝数变异)。 结论: PICU死亡病例的遗传基因主要为免疫、代谢和神经肌肉遗传病基因。对存在家族史、CCC和入院时存在重症感染、精神反应差或昏迷、中重度贫血、血小板减少、迁延性腹泻、肌力或肌张力异常等特征的患儿应重点关注并尽早行基因检测。.
引用
- Wang Y, Wang YX, Qian YY, et al. [Analysis of genetic etiology of 234 deaths in the pediatric intensive care unit with suspected genetic diseases]. Zhonghua Er Ke Za Zhi. 2024. PMID: 39039876. doi:10.3760/cma.j.cn112140-20240207-00102
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。